Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825202 | Clinical Therapeutics | 2015 | 11 Pages |
Abstract
In this assessment of patients with TNBC treated in a community oncology setting, eribulin was utilized in later lines compared with the other agents. However, comparable drug activity was reported among the 4 agents.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
George BPharm, PhD, Stefan MD, Claudio Pharm D, MPH, David PhD, Hope MD,